Effect of Sildenafil Citrate on Insulin Resistance and Endothelial Function in Obese African American Women.

Trial Profile

Effect of Sildenafil Citrate on Insulin Resistance and Endothelial Function in Obese African American Women.

Completed
Phase of Trial: Phase I/II

Latest Information Update: 30 Mar 2017

At a glance

  • Drugs Sildenafil (Primary)
  • Indications Insulin resistance; Metabolic syndrome
  • Focus Pharmacodynamics
  • Most Recent Events

    • 01 Sep 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 07 Jul 2012 Company (Pfizer) added in association as reported by ClinicalTrials.gov.
    • 21 Jun 2011 New source identified and integrated (Vanderbilt University Institutional Review Board: 100713).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top